Virtus Fund Advisers, LLC Biocryst Pharmaceuticals Inc Transaction History

Virtus Fund Advisers, LLC

  • $20.2 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
BUY
$10.5 - $14.2 $19,950 - $26,980
1,900 New
1,900 $21,000
Q3 2022

Nov 14, 2022
SELL
$10.79 - $14.81 $766,963 - $1.05 Million
-71,081 Closed
0 $0
Q4 2017

Feb 09, 2018
BUY
$4.16 - $5.33 $295,696 - $378,861
71,081
71,081 $349,000

Others Institutions Holding BCRX

# of Institutions
280
Shares Held
172M
Call Options Held
625K
Put Options Held
739K
View Full List

About BIOCRYST PHARMACEUTICALS INC

BCRX Quotes by TradingView
  • Ticker BCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,944,992
  • Market Cap $1.39B
  • Description
  • BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...
More about BCRX
Track This Portfolio

Track Virtus Fund Advisers, LLC Portfolio

Follow Virtus Fund Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtus Fund Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtus Fund Advisers, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email